Oct 7, 2026 08:00AM
May 26, 2026 08:00AM
May 26, 2026 08:00AM
May 14, 2026 04:30PM
May 13, 2026 08:00AM
May 1, 2026 09:36AM
May 1, 2026 07:01AM ARCHIMED to acquire Esperion for $3.16 per share plus milestone payments
May 1, 2026 07:00AM
Apr 23, 2026 08:00AM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:05PM
Apr 2, 2026 04:00PM
Apr 2, 2026 04:00PM
Mar 31, 2026 08:00AM Esperion to Participate in 25th Annual Needham Virtual Healthcare Conference
Mar 30, 2026 08:05AM
Mar 30, 2026 08:00AM
Mar 17, 2026 08:00AM
Mar 16, 2026 06:31AM
Mar 16, 2026 06:30AM
Mar 13, 2026 05:40AM
Mar 10, 2026 12:17PM H.C. Wainwright Reiterates Buy Rating on Esperion Therapeutics (ESPR): "we expect continued growth"
Mar 10, 2026 06:00AM
Mar 3, 2026 06:00AM
Mar 3, 2026 06:00AM
Feb 24, 2026 08:00AM
Feb 18, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 17, 2026 08:00AM Esperion Reaches Settlement Agreement with Fifth ANDA Filer Not to Market Generic Version of NEXLETOL® (bempedoic acid) & NEXLIZET® (bempedoic acid & ezetimibe) Prior to April 19, 2040
Feb 17, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 11, 2026 04:30PM
Jan 11, 2026 06:00PM
Jan 5, 2026 08:00AM
Dec 19, 2025 08:00AM
Jul 24, 2025 12:48PM Esperion Therapeutics (ESPR) on watch on vague chatter
Jul 1, 2025 08:07AM
Jul 1, 2025 08:06AM
May 8, 2025 06:30AM
May 8, 2025 06:30AM
Mar 4, 2025 06:00AM
Dec 18, 2024 07:01AM
Dec 18, 2024 07:00AM Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions
Jan 4, 2022 08:00AM
Jan 4, 2022 08:00AM
May 5, 2021 09:30AM
Apr 26, 2021 04:27PM
Apr 26, 2021 04:07PM
Apr 26, 2021 04:07PM
Feb 14, 2020 05:40AM Citi Downgrades Esperion Therapeutics (ESPR) to Neutral
Jun 26, 2019 04:12PM

1,199,226 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All